Gizem Gencay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gizem Gencay has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Beyza Gurler
Department of Medical Biotechnology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey
1 shared publication - Emel Baloglu
Department of Medical Pharmacology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey
1 shared publication - Muhammed Canik
Faculty of Science, Department of Biology Sakarya University Serdivan Sakarya Türkiye
1 shared publication - Nazan Deniz Yön Ertuğ
Faculty of Science, Department of Biology Sakarya University Serdivan Sakarya Türkiye
1 shared publication - Nurbanu Zengin
Faculty of Science, Department of Biology Sakarya University Serdivan Turkey
1 shared publication - Sevda Bagdatli
Faculty of Science, Department of Biology Sakarya University Serdivan Turkey
1 shared publication
Latest Publications
- Open Access
- 17 August 2026
- Published by Wiley in Journal of Applied Toxicology
Bisphenol A and Its Analogs: Toxicity Analysis in Mouse and Rat Liver—A Review
Bisphenol A (BPA) and its analogs are widely recognized for their use in industry and plastic manufacturing. Consequently, humans and animals are continually exposed to various substances in their daily lives. This review evaluates the hepatic toxicity of BPA and its analogs in mice and rats, with particular emphasis on molecular mechanisms, histopathological alterations, and interspecies differences. Studies indicate that BPA induces increased hepatotoxicity by disrupting key cellular processes, including oxidative stress, inflammation, apoptosis, and lipid metabolism. The reduction in antioxidant enzyme activities, dysregulated activation of the NRF2 pathway, imbalance in the BAX/BCL‐2 ratio, and upregulation of lipogenic genes led to structural and functional abnormalities in the liver. Histopathologically, vacuolization, sinusoidal dilation, inflammatory cell infiltration, and fibrosis are among the most frequently reported findings. Although BPA analogs are often promoted as safer alternatives, current evidence indicates that this assumption is not accurate. Taken together, the conclusions of these studies demonstrate that bisphenol exposure poses a significant risk to liver health, underscoring the need to reassess the use of these compounds.
- 17 August 2026
- Published by Wiley in Journal of Applied Toxicology
Open AccessBisphenol A and Its Analogs: Toxicity Analysis in Mouse and Rat Liver—A Review
Bisphenol A (BPA) and its analogs are widely recognized for their use in industry and plastic manufacturing. Consequently, humans and animals are continually exposed to various substances in their daily lives. This review evaluates the hepatic toxicity of BPA and its analogs in mice and rats, with particular emphasis on molecular mechanisms, histopathological alterations, and interspecies differences. Studies indicate that BPA induces increased hepatotoxicity by disrupting key cellular processes, including oxidative stress, inflammation, apoptosis, and lipid metabolism. The reduction in antioxidant enzyme activities, dysregulated activation of the NRF2 pathway, imbalance in the BAX/BCL‐2 ratio, and upregulation of lipogenic genes led to structural and functional abnormalities in the liver. Histopathologically, vacuolization, sinusoidal dilation, inflammatory cell infiltration, and fibrosis are among the most frequently reported findings. Although BPA analogs are often promoted as safer alternatives, current evidence indicates that this assumption is not accurate. Taken together, the conclusions of these studies demonstrate that bisphenol exposure poses a significant risk to liver health, underscoring the need to reassess the use of these compounds.
- Open Access
- 12 October 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (10) , 8277-8288
Hypoxia and HIF-1α Regulate the Activity and Expression of Na,K-ATPase Subunits in H9c2 Cardiomyoblasts
The optimal function of the Na,K-ATPase (NKA) pump is essential for the heart. In ischemic heart disease, NKA activity decreases due to the decreased expression of the pump subunits. Here, we tested whether the hypoxia-inducible transcription factor (HIF-1α), the key signaling molecule regulating the adaptation of cells to hypoxia, is involved in controlling the expression and cellular dynamics of α1- and β1-NKA isoforms and of NKA activity in in-vitro hypoxic H9c2 cardiomyoblasts. HIF-1α was silenced through adenoviral infection, and cells were kept in normoxia (19% O2) or hypoxia (1% O2) for 24 h. We investigated the mRNA and protein expression of α1-, β1-NKA using RT-qPCR and Western blot in whole-cell lysates, cell membranes, and cytoplasmic fractions after labeling the cell surface with NHS-SS-biotin and immunoprecipitation. NKA activity and intracellular ATP levels were also measured. We found that in hypoxia, silencing HIF-1α prevented the decreased mRNA expression of α1-NKA but not of β1-NKA. Hypoxia decreased the plasma membrane expression of α1-NKA and β1- NKA compared to normoxic cells. In hypoxic cells, HIF-1α silencing prevented this effect by inhibiting the internalization of α1-NKA. Total protein expression was not affected. The decreased activity of NKA in hypoxic cells was fully prevented by silencing HIF-1α independent of cellular ATP levels. This study is the first to show that in hypoxic H9c2 cardiomyoblasts, HIF-1α controls the internalization and membrane insertion of α1-NKA subunit and of NKA activity. The mechanism behind this regulation needs further investigation.
- 12 October 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (10) , 8277-8288
Open AccessHypoxia and HIF-1α Regulate the Activity and Expression of Na,K-ATPase Subunits in H9c2 Cardiomyoblasts
The optimal function of the Na,K-ATPase (NKA) pump is essential for the heart. In ischemic heart disease, NKA activity decreases due to the decreased expression of the pump subunits. Here, we tested whether the hypoxia-inducible transcription factor (HIF-1α), the key signaling molecule regulating the adaptation of cells to hypoxia, is involved in controlling the expression and cellular dynamics of α1- and β1-NKA isoforms and of NKA activity in in-vitro hypoxic H9c2 cardiomyoblasts. HIF-1α was silenced through adenoviral infection, and cells were kept in normoxia (19% O2) or hypoxia (1% O2) for 24 h. We investigated the mRNA and protein expression of α1-, β1-NKA using RT-qPCR and Western blot in whole-cell lysates, cell membranes, and cytoplasmic fractions after labeling the cell surface with NHS-SS-biotin and immunoprecipitation. NKA activity and intracellular ATP levels were also measured. We found that in hypoxia, silencing HIF-1α prevented the decreased mRNA expression of α1-NKA but not of β1-NKA. Hypoxia decreased the plasma membrane expression of α1-NKA and β1- NKA compared to normoxic cells. In hypoxic cells, HIF-1α silencing prevented this effect by inhibiting the internalization of α1-NKA. Total protein expression was not affected. The decreased activity of NKA in hypoxic cells was fully prevented by silencing HIF-1α independent of cellular ATP levels. This study is the first to show that in hypoxic H9c2 cardiomyoblasts, HIF-1α controls the internalization and membrane insertion of α1-NKA subunit and of NKA activity. The mechanism behind this regulation needs further investigation.